eMedicine Specialties > Neurology > Pediatric Neurology
Infantile Spasm (West Syndrome)
Updated: Apr 10, 2006
Introduction
Background
West syndrome is composed of the triad of infantile spasms, an interictal EEG pattern termed hypsarrhythmia, and mental retardation, although the diagnosis can be made even if one of the 3 elements is missing (according to the international classification). This severe epilepsy syndrome is an age-dependent expression of a damaged brain. The term "infantile spasms" has been used to describe the seizure type, the epilepsy syndrome, or both. In this article, the term "infantile spasms" is synonymous with West syndrome.
The syndrome's namesake, Dr W J West, gave the first detailed description of infantile spasms, as they occurred in his child. In a letter to the editor of The Lancet in 1841, West described the events as "bobbings" that "cause a complete heaving of the head forward towards his knees, and then immediately relaxing into the upright position these bowings and relaxings would be repeated alternately at intervals of a few seconds, and repeated from 10 to 20 or more times at each attack, which attack would not continue more than 2 or 3 minutes; he sometimes has 2, 3 or more attacks in the day."
This detailed clinical description was followed approximately 100 years later by the report of the typical interictal EEG pattern termed hypsarrhythmia. Most patients with infantile spasms have some degree of developmental retardation.
The eponym West syndrome was created in the early 1960s by Drs. Gastaut, Poirier, and Pampiglione.
Pathophysiology
Infantile spasms are believed to reflect abnormal interactions between the cortex and brainstem structures. Focal lesions early in life may secondarily affect other sites in the brain, and hypsarrhythmia may represent this abnormal activity arising from multiple brain sites. The frequent onset of infantile spasms in infancy suggests that an immature central nervous system may be important in the pathogenesis. The brain-adrenal axis also may be involved. One theory states that the effect of different stressors in the immature brain produces an abnormal excessive secretion of corticotropin-releasing hormone, causing spasms. The clinical response to adrenocorticotropic hormone (ACTH) and glucocorticoids can be explained by suppression of corticotropin-releasing hormone (CRH) production.
Frequency
United States
Infantile spasm constitutes 2% of childhood epilepsies but 25% of epilepsy with onset in the first year of life. The rate of infantile spasm is estimated between 2.5 to 6.0 per 10,000 live births. Its prevalence rate is 1.5-2.0 per 10,000 children aged 10 years or younger.
International
Infantile spasm occurs in 0.05 (Estonia) to 0.41 (Oulu, Finland) of 1000 live births and in 1.4% (Estonia), 4.2% (Odense, Denmark), and 7.6% (Tampere, Finland) of children with epilepsy.
Mortality/Morbidity
The premature death rate ranges from 5-31%. The upper limit comes from a study of 214 Finnish children with a history of infantile spasms who were followed for a mean of 25 years (range, 20-30 y). Most of the deaths (61%) occurred at or before age 10 years, while only 10% occurred after age 20 years.
Sex
Although males are affected slightly more often than females, no significant gender difference is noted.
Age
Ninety percent of infantile spasms begin in those younger than 12 months. Peak onset is at age 4-6 months.
Clinical
History
- Ictal manifestations
- Spasms begin with a sudden, rapid, tonic contraction of trunk and limb musculature that gradually relaxes over 0.5-2 seconds.
- Contractions can last 5-10 seconds.
- The intensity may vary from a subtle head nodding to a powerful contraction of the body.
- Infantile spasms usually occur in clusters, often several dozens, separated by 5-30 seconds.
- Spasms frequently occur just before sleep or upon awakening. They can be observed during sleep, although this is rare.
- Spasms can be flexor, extensor, or a mixture of flexion and extension.
- Flexor spasms consist of brief contractions of the flexor muscles of the neck, trunks, and limbs, resulting in a brief jerk. They may resemble a self-hugging motion and often are associated with a cry. The patient then relaxes, and the jerk repeats. These attacks occur in clusters throughout the day and last anywhere from less than 1 minute to 10-15 minutes or longer in some patients.
- Extensor spasms consist of contractions of the extensor musculature with sudden extension of the neck and trunk with extension and abduction of the limbs. Extensor spasms and asymmetric or unilateral spasms often are associated with symptomatic cases.
- Mixed spasms are the most common type, consisting of flexion of the neck and arms with extension of the legs, or flexion of the legs with extension of the arms.
- In different series the frequency of the 3 spasm types were 42-50% mixed, 34-42% flexor, and 19-23% extensor.
- Spasms begin with a sudden, rapid, tonic contraction of trunk and limb musculature that gradually relaxes over 0.5-2 seconds.
- Interictal manifestations: An arrest or regression in psychomotor development accompanies the onset of spasms in 70-95% of patients.
- Family history: A family history of infantile spasms is uncommon but as many as 17% of patients may have a family history of any epilepsy.
Physical
- General physical examination
- Physical examination can be important in helping to identify specific etiologies that may have both systemic and neurological symptoms (eg, tuberous sclerosis complex).
- Often a patient with infantile spasms has normal findings on general physical examination. No pathognomonic physical findings are present in patients with infantile spasms.
- If abnormalities in the general physical examination are noted (eg, adenoma sebaceum, ash leaf macules), specific etiologies may be suggested.
- Use a Wood lamp to examine the skin.
- Patients may exhibit moderate-to-severe growth delay; this is a nonspecific finding and more a reflection of the underlying brain injury than of a specific epilepsy syndrome.
- Neurologic examination
- The neurologic examination in patients with infantile spasms demonstrates abnormalities in mental status function, specifically deficits in cognitive function consistent with developmental delay or regression.
- Abnormalities in level of consciousness, cranial nerve function, and motor/sensory/reflex examination are nonspecific findings and more a reflection of the underlying brain injury or effect of anticonvulsant medications than of the syndrome.
- No pathognomonic findings are present on neurologic examination in patients with infantile spasms.
Causes
Infantile spasms (West syndrome) can be classified according to its suspected etiology as symptomatic, cryptogenic, or idiopathic.
- Symptomatic
- Patients are diagnosed with symptomatic infantile spasms if an identifiable factor is responsible for the syndrome. Virtually any disorder that can produce brain damage can be associated with infantile spasms.
- The list of etiologies can be subdivided into prenatal disorders, perinatal disorders, and postnatal disorders.
- Prenatal disorders include hydrocephalus, microcephaly, hydranencephaly, schizencephaly, polymicrogyria, Sturge-Weber syndrome, incontinentia pigmenti, tuberous sclerosis, trisomy 21, hypoxic-ischemic encephalopathies, congenital infections, and trauma.
- Perinatal disorders include hypoxic-ischemic encephalopathies, meningitis, encephalitis, trauma, and intracranial hemorrhages.
- Postnatal disorders include pyridoxine dependency, nonketotic hyperglycinemia, maple syrup urine disease, phenylketonuria, mitochondrial encephalopathies, meningitis, encephalitis, degenerative diseases, biotinidase deficiency, and trauma.
- Evaluating children with infantile spasms for possible tuberous sclerosis is critical, as this is the single most common disorder, comprising 10-30% of prenatal cases. Tuberosis sclerosis is an autosomally dominant inherited disease with variable manifestations including cardiac tumors, kidney tumors, cutaneous malformations such as ash-leaf hypopigmented lesions, and seizures. In more than a few patients, the family diagnosis of tuberous sclerosis is found only after a child presents with infantile spasms, and an extensive workup of the child and subsequently the family reveals the genetic disease.
- Of patients with infantile spasms, 70-75% have symptomatic epilepsy. This percentage depends on the degree of sophistication of diagnostic studies. Development of more exquisite neurodiagnostic techniques will alter the relative proportion of symptomatic, cryptogenic, and idiopathic cases.
- Cryptogenic
- Patients have cryptogenic infantile spasms if no cause is identified but a cause is suspected and the epilepsy is presumed to be symptomatic.
- The proportion of cryptogenic cases varies from 8-42%. This wide range may be related to variations in the definition of the term "cryptogenic" and the age of diagnosis, since assessment of developmental level in early infancy is difficult.
- Idiopathic
- Patients may be considered to have idiopathic infantile spasms if normal psychomotor development occurs prior to the onset of symptoms, no underlying disorders or definite presumptive causes are present, and no neurological or neuroradiological abnormalities exist. Some investigators use the terms "idiopathic" and "cryptogenic" interchangeably.
- The percentage of idiopathic cases reportedly is 9-14%.
- Family history: A family history of infantile spasms is uncommon but as many as 17% of patients may have a family history of any epilepsy.
More on Infantile Spasm (West Syndrome) |
Overview: Infantile Spasm (West Syndrome) |
| Differential Diagnoses & Workup: Infantile Spasm (West Syndrome) |
| Treatment & Medication: Infantile Spasm (West Syndrome) |
| Follow-up: Infantile Spasm (West Syndrome) |
| Multimedia: Infantile Spasm (West Syndrome) |
| References |
| Next Page » |
References
Aicardi J, Mumford JP, Dumas C, et al. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups. Epilepsia. Jul 1996;37(7):638-42. [Medline].
Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. Nov 1999;40(11):1627-33. [Medline].
Asarnow RF, LoPresti C, Guthrie D, et al. Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev Med Child Neurol. Jul 1997;39(7):430-40. [Medline].
Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. Mar 1996;97(3):375-9. [Medline].
Blennow G, Starck L. High dose B6 treatment in infantile spasms. Neuropediatrics. Feb 1986;17(1):7-10. [Medline].
Bobele GB, Bodensteiner JB. The treatment of infantile spasms by child neurologists. J Child Neurol. Oct 1994;9(4):432-5. [Medline].
Chugani HT. Infantile spasms. Curr Opin Neurol. Apr 1995;8(2):139-44. [Medline].
Cianchetti C, Pruna D, Coppola G. Low-dose lamotrigine in West syndrome. Epilepsy Res. Sep 2002;51(1-2):199-200. [Medline].
Commission on Classification and Terminology of the International League Agains. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. Jul-Aug 1989;30(4):389-99. [Medline].
Czochanska J, Langner-Tyszka B, Losiowski Z, et al. Children who develop epilepsy in the first year of life: a prospective study. Dev Med Child Neurol. Apr 1994;36(4):345-50. [Medline].
Debus OM, Kurlemann G. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia. Feb 2004;45(2):103-8. [Medline].
Donat JF, Lo WD. Asymmetric hypsarrhythmia and infantile spasms in west syndrome. J Child Neurol. Jul 1994;9(3):290-6. [Medline].
Drury I, Beydoun A, Garofalo EA, et al. Asymmetric hypsarrhythmia: clinical electroencephalographic and radiological findings. Epilepsia. Jan 1995;36(1):41-7. [Medline].
Eisermann MM, DeLaRaillère A, Dellatolas G. Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment. Epilepsy Res. Jun-Jul 2003;55(1-2):21-7. [Medline].
Fejerman N, Cersosimo R, Caraballo R, et al. Vigabatrin as a first-choice drug in the treatment of West syndrome. J Child Neurol. Mar 2000;15(3):161-5. [Medline].
Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. Dec 1998;39(12):1324-8. [Medline].
Glauser TA. Pediatric epilepsy syndromes. Curr Opin Pediatr. Dec 1995;7(6):640-9. [Medline].
Glauser TA. Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia. 2004;45 Suppl 5:23-6. [Medline].
Goh S, Kwiatkowski DJ, Dorer DJ. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology. Jul 26 2005;65(2):235-8. [Medline].
Hammoudi DS, Lee SS, Madison A. Reduced visual function associated with infantile spasms in children on vigabatrin therapy. Invest Ophthalmol Vis Sci. Feb 2005;46(2):514-20. [Medline].
Hancock E, Osborne JP. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol. Feb 1999;14(2):71-4. [Medline].
Hrachovy RA, Frost JD Jr, Kellaway P. Hypsarrhythmia: variations on the theme. Epilepsia. Jun 1984;25(3):317-25. [Medline].
Hrachovy RA, Frost JD Jr, Kellaway P, et al. Double-blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr. Oct 1983;103(4):641-5. [Medline].
Ito M. Antiepileptic drug treatment of West syndrome. Epilepsia. 1998;39 Suppl 5:38-41. [Medline].
Ito M, Seki T, Takuma Y. Current therapy for West syndrome in Japan. J Child Neurol. Jun 2000;15(6):424-8. [Medline].
Kivity S, Lerman P, Ariel R. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. Mar 2004;45(3):255-62. [Medline].
Kondo Y, Okumura A, Watanabe K. Comparison of two low dose ACTH therapies for West syndrome: their efficacy and side effect. Brain Dev. Aug 2005;27(5):326-30. [Medline].
Lux AL, Edwards SW, Hancock E. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. Nov 2005;4(11):712-7. [Medline].
Lux AL, Edwards SW, Hancock E. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. Nov 13-19 2004;364(9447):1773-8. [Medline].
Mackay M, Weiss S, Snead OC. Treatment of infantile spasms: an evidence-based approach. Int Rev Neurobiol. 2002;49:157-84. [Medline].
Mackay MT, Weiss SK, Adams-Webber T. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. May 25 2004;62(10):1668-81. [Medline].
Mahdi AH, Yohannan MD, Patel PJ, et al. Computerized tomography of brain in infantile spasms (West syndrome). Pediatr Radiol. 1990;21(1):9-11. [Medline].
Muroi J, Okuno T, Kuno C, et al. An MRI study of the myelination pattern in West syndrome. Brain Dev. May-Jun 1996;18(3):179-84. [Medline].
Pies NJ, Beardsmore CW. West & West syndrome--a historical sketch about the eponymous doctor, his work and his family. Brain Dev. Mar 2003;25(2):84-101. [Medline].
Pietz J, Benninger C, Schafer H, et al. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia. Jul-Aug 1993;34(4):757-63. [Medline].
Riikonen R. The latest on infantile spasms. Curr Opin Neurol. Apr 2005;18(2):91-5. [Medline].
Shields WD. Catastrophic epilepsy in childhood. Epilepsia. 2000;41 Suppl 2:S2-6. [Medline].
Stafstrom CE, Konkol RJ. Infantile spasms in children with Down syndrome. Dev Med Child Neurol. Jul 1994;36(7):576-85. [Medline].
Veggiotti P, Cieuta C, Rex E, et al. Lamotrigine in infantile spasms [letter]. Lancet. Nov 12 1994;344(8933):1375-6. [Medline].
Wang MC, Mak SC, Chi CS, et al. A long-term follow-up study of West syndrome. Chung Hua I Hsueh Tsa Chih (Taipei). Mar 1994;53(3):158-62. [Medline].
Watanabe K. Medical treatment of West syndrome in Japan. J Child Neurol. Mar 1995;10(2):143-7. [Medline].
West WJ. Infantile spasm. Lancet. 1841;1:724.
Wyllie E. The Treatment of Epilepsy: Principles and Practice. 1st ed. Philadelphia:. Lippincott Williams & Wilkins;1993.
Yamauchi T, Aikawa H. Efficacy of zonisamide: our experience. Seizure. Dec 2004;13 Suppl 1:S41-8; discussion S49. [Medline].
Yanagaki S, Oguni H, Yoshii K. Zonisamide for West syndrome: a comparison of clinical responses among different titration rate. Brain Dev. Jun 2005;27(4):286-90. [Medline].
Zupanc ML. Infantile spasms. Expert Opin Pharmacother. Nov 2003;4(11):2039-48. [Medline].
Further Reading
Keywords
infantile spasms, hypsarrhythmia, developmental delay, West syndrome, mental retardation, epilepsy syndrome
Overview: Infantile Spasm (West Syndrome)